Nexgenia
Facts
- HQ
- Seattle
- Sectors
- Biotechnology, Life Sciences
- Stage
- null
- Members see funding amounts. .
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about Nexgenia
GeekWire lists 50+ women VCs and angel investors backing startups in Seattle and Portland as region adds female leaders
GeekWire compiled a list of more than 50 women angel and venture investors active in Seattle and Portland, noting that increasing female representation in VC correlates with more funding for women-led startups despite women receiving under 3% of VC funding in 2017. The piece highlights research showing women-led startups outperform peers, points to structural gaps in VC firms, and notes growing efforts and initiatives to support female founders and investors.
Seattle Startup Nexgenia Raises $2M to Broaden Polymer Reagent Technology for Immunotherapy Applications
Seattle biotech startup Nexgenia, led by CEO Ron Myers, raised $2 million to expand its polymer-based reagents for sorting cells in immunotherapy production to new applications. The funding, led by the W Fund and Washington Research Foundation, will support further research into diverse uses of their technology beyond cancer treatment.
Questions about Nexgenia
What is Nexgenia?
Seattle
Who invested in Nexgenia, and how much has it raised?
Members of Seattle Flow see Nexgenia's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Nexgenia based?
Nexgenia is headquartered in Seattle.